Data as of:
brimindinvest.com / compare / hca-vs-uhsLIVE
HCA
HCA Healthcare, Inc. · Healthcare
$427.71
+5.08% this month
VERSUS
COMPARE
UHS
Universal Health Services, Inc. · Healthcare
$176.69
+2.53% this month
Comparison scoreboard
HCA LEADS 3/5
AI Scorei
HCA 53.3
UHS 38.1
1Y Returni
HCA +6.64%
UHS -6.07%
Fwd P/Ei
HCA 13.01
UHS 7.14
Target Up.i
HCA +8.06%
UHS +12.98%
Op. Margini
HCA 15.16%
UHS 11.14%
Metrics last refreshed: 9/20/2026
Quick take

HCA vs UHS Stock Comparison: AI Score, Valuation, Performance and Upside

ShareXLinkedInRedditFacebookWhatsApp

HCA Healthcare and Universal Health Services both operate hospital networks, but HCA Healthcare concentrates on acute care hospitals at a much larger scale, while Universal Health Services combines acute care hospitals with a substantial behavioral health facility segment.

HCA Healthcare offers scale advantages through the largest for-profit acute care hospital network, while Universal Health Services offers diversification through its combined acute care and behavioral health segments. Consider whether you prefer HCA's acute care scale or UHS's behavioral health diversification.

Live analysis · updated 9/20/2026

HCA holds the edge across 3 of 5 key metrics in this comparison. HCA has delivered stronger 1-year price return (+6.64% vs -6.07%), though UHS has the better forward P/E setup (7.14x vs 13.01x for HCA). HCA leads on both revenue growth (8.70%) and operating margin (15.16%), suggesting a stronger fundamental setup on both dimensions. Analyst consensus implies meaningfully more upside for UHS (+12.98%) than for HCA (+8.06%).

Want a full valuation workup? 46-section report — AI Score, Monte Carlo forecast, bull/bear case, DCF, and more.
Normalized 1Y performance
HCA
UHS
Recent returns
HCA
UHS
Analyst price targets & sentiment

Human Wall Street analysts' price targets, typically implying a ~12-month view — a separate signal from this site's own AI Prediction Signal further down the page, which is a 5-/30-day machine-learning forecast based on price history alone.

HCA
Price target range
analyst mean$451.48
current price$427.71
+8.1% upside to analyst mean
UHS · 16 analysts
STRONG BUYHOLDSTRONG SELL
Buy (2.2/5.0)
7 Buy / 12 Hold / 1 Sell
Price target range
analyst low$186.41
analyst high$280.00
analyst mean$193.94
current price$176.69
+13.0% upside to analyst mean
Who should consider this stock?
HCA may suit investors who:
  • Want exposure to the largest for-profit acute care hospital network in the United States
  • Value the negotiating leverage and purchasing efficiencies that come with HCA's scale
  • Believe broad geographic diversification across acute care hospitals supports stable demand
  • Prefer a more concentrated acute care hospital business model
UHS may suit investors who:
  • Want diversified exposure combining acute care hospitals with a substantial behavioral health facility segment
  • Believe growing recognition of mental health treatment needs supports long-term behavioral health demand
  • Value the diversification benefits of two distinct healthcare demand drivers within one company
  • Are comfortable with a smaller overall scale relative to the largest hospital operators
Performance & AI score
Performance & AI score
MetricHCAUHS
AI scorei53.338.1
AI ranki#345#1413
Latest closei$427.71$176.69
1M returni+5.08%+2.53%
6M returni-14.40%-5.62%
1Y returni+6.64%-6.07%
$10,000 invested — hypothetical growth (dividends reinvested)

How much would $10,000 be worth today if invested at the start of each period, with all dividends reinvested?

$10,000 invested — hypothetical growth (dividends reinvested)
PeriodHCAUHS
1Y ago$10.66K (+6.6%)
started 2025-09-18
$9.39K (-6.1%)
started 2025-09-18
5Y ago$17.86K (+78.6%)
started 2021-09-20
$12.71K (+27.1%)
started 2021-09-20
10Y ago$64.72K (+547.2%)
started 2016-09-19
$15.44K (+54.4%)
started 2016-09-19

Hypothetical — past performance does not guarantee future results.

Valuation & upside potential
Valuation & upside potential
MetricHCAUHS
Market capi$90.46B$10.12B
Trailing P/Ei14.017.01
Forward P/Ei13.017.14
Price/SalesiN/A0.76
EV/Revenuei1.850.85
Analyst targeti$451.48$193.94
Target upsidei+8.06%+12.98%
Growth, profitability & risk
Growth, profitability & risk
MetricHCAUHS
Revenue growthi8.70%8.30%
Earnings growthi11.60%10.10%
EPS growthi+11.60%+10.10%
FCF margini+4.79%+2.75%
Operating margini15.16%11.14%
Profit margini8.77%8.42%
ROIC proxyi13631.68%20.95%
Return on equityi13631.68%20.95%
Dividend yieldi0.75%0.47%
Payout ratioi10.06%3.27%
Dividend growth streakiNo increase yetNo increase yet
Betai1.111.06
Debt/equityiN/A68.74
Current ratioi0.991.12
Quick ratioi0.780.89
Correlation

Over the past year, HCA and UHS have moved moderately in the same direction (correlation of 0.66), based on daily returns.

1Y
0.66
-1.0+1.0
5Y
0.72
-1.0+1.0
10Y
0.77
-1.0+1.0
Drawdown & downside risk

Lower drawdown and smaller single-period drops generally indicate a smoother ride, though they do not guarantee lower future risk.

1Y risk snapshot
HCA max drawdowni33.72%
UHS max drawdowni42.19%
HCA max wkly dropi14.06%
UHS max wkly dropi12.32%
5Y risk snapshot
HCA max drawdowni39.49%
UHS max drawdowni43.34%
HCA max wkly dropi22.87%
UHS max wkly dropi20.55%
10Y risk snapshot
HCA max drawdowni54.74%
UHS max drawdowni56.30%
HCA max wkly dropi39.49%
UHS max wkly dropi38.54%
Performance metrics by period
Performance metrics by period
PeriodMetricHCAUHS
1YGrowthi+6.64%-6.07%
CAGRi+6.65%-6.07%
Volatilityi30.68%32.21%
Sharpe ratioi0.22-0.17
Sortino ratioi0.31-0.23
Max drawdowni33.72%42.19%
Current drawdowni21.54%27.64%
Avg drawdowni13.24%20.00%
Ulcer Indexi17.34%24.30%
Max daily dropi8.77%11.44%
Max wkly dropi14.06%12.32%
5YGrowthi+73.05%+24.59%
CAGRi+11.60%+4.50%
Volatilityi30.04%32.07%
Sharpe ratioi0.370.16
Sortino ratioi0.500.22
Max drawdowni39.49%43.34%
Current drawdowni21.54%27.64%
Avg drawdowni11.66%16.34%
Ulcer Indexi15.29%19.94%
Max daily dropi21.82%13.96%
Max wkly dropi22.87%20.55%
10YGrowthi+503.47%+48.71%
CAGRi+19.70%+4.05%
Volatilityi32.99%34.55%
Sharpe ratioi0.580.16
Sortino ratioi0.830.22
Max drawdowni54.74%56.30%
Current drawdowni21.54%27.64%
Avg drawdowni10.01%14.65%
Ulcer Indexi13.86%18.37%
Max daily dropi21.82%22.26%
Max wkly dropi39.49%38.54%
AI Prediction Signali
Members only
Next 5 trading days
HCA
+2.8%BUY
UHS
+1.1%HOLD
Next 30 trading days
HCA
+6.4%BUY
UHS
+3.2%HOLD

Sign up to unlock AI price predictions

ML model trained on historical prices · 14-day free trial · No credit card required
Business comparison
Business comparison
CategoryHCAUHS
CompanyHCA Healthcare, Inc.Universal Health Services, Inc.
SectorHealthcareHealthcare
IndustryMedical Care FacilitiesMedical Care Facilities
Core businessThe largest for-profit hospital operator in the United States, operating a large network of acute care hospitals and related healthcare facilities providing a broad range of medical and surgical services.A hospital operator running both acute care hospitals and a substantial behavioral health facility network, providing psychiatric and substance abuse treatment services alongside general medical and surgical care.
Investor focusPatient volume and acuity mix trends, reimbursement rate negotiations with payers, and margin performance across the hospital network.Behavioral health segment growth and occupancy trends, acute care segment volume and margin performance, and capital allocation between the two segments.
HCA strengths
  • Scale as the largest for-profit hospital operator provides negotiating leverage with payers and purchasing efficiencies
  • Broad geographic footprint across acute care hospitals provides diversified exposure to regional healthcare demand
  • Comprehensive service line offerings across surgical, medical, and specialty care support revenue diversification
UHS strengths
  • Behavioral health segment provides diversified exposure to psychiatric and substance abuse treatment demand distinct from acute care hospital cycles
  • Combination of acute care and behavioral health segments provides diversification across different healthcare demand drivers
  • Growing recognition of mental health treatment needs supports long-term behavioral health facility demand
Risks to watch — HCA
  • Hospital volumes and payer mix are sensitive to broader economic conditions and employment-based insurance coverage trends
  • Reimbursement rate negotiations with government and commercial payers directly affect revenue per patient
  • Labor cost inflation, particularly for nursing staff, can pressure margins across the hospital industry
Risks to watch — UHS
  • Behavioral health facility staffing and regulatory compliance requirements carry ongoing operational complexity
  • Acute care segment remains exposed to the same reimbursement and labor cost pressures affecting the broader hospital industry
  • Smaller overall scale relative to the largest hospital operators limits some negotiating leverage advantages
Frequently asked questions
HCA offers scale advantages through the largest for-profit acute care hospital network in the United States. UHS offers diversification through its combined acute care and behavioral health segments. The better choice depends on whether you prefer acute care scale or behavioral health diversification.
Free public comparison

Want deeper AI forecasts?

This comparison page is public and free forever. Subscribers can unlock saved watchlists, full AI rankings, detailed forecasts, and interactive analysis tools.

In-Depth Reports

Full valuation workup with AI Score, Monte Carlo forecast, and bull/bear case — free preview, premium data from $3.99.

Related comparisons
More comparisons
Browse all 1,000 comparisons
ShareXLinkedInRedditFacebookWhatsApp